Chloroquine, hydroxychloroquine and COVID-19

T. B. Ericksona Division of Medical Toxicology, Department of Emergency Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA;b Harvard Humanitarian Initiative, Harvard University, Cambridge, MA, USACorrespondence[email protected]

https://orcid.org/0000-0002-1809-4805 View further author information

P. R. Chaia Division of Medical Toxicology, Department of Emergency Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA;c The Fenway Institute, Boston, MA, USA;d Koch Institute for Integrated Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA;e Department of Psychosocial Oncology and Palliative Care, Dana Farber Cancer Institute, Boston, MA, USAView further author information

E. W. Boyera Division of Medical Toxicology, Department of Emergency Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA;c The Fenway Institute, Boston, MA, USAView further author information

Chloroquine, hydroxychloroquine and COVID-19

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Chloroquine, hydroxychloroquine and COVID-19

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date